Sumitomo Pharma Co Ltd (FRA:DPM)
€ 3.62 0.04 (1.12%) Market Cap: 1.47 Bil Enterprise Value: 3.14 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 55/100

Q2 2023 Sumitomo Pharma Co Ltd Earnings Presentation Transcript

Nov 01, 2022 / NTS GMT
Release Date Price: €6.65 (-2.21%)

Nov 01, 2022 / NTS GMT
Presentation
Nov 01, 2022 / NTS GMT

=====================
Corporate Participants
=====================
* Hiroshi Nomura
Sumitomo Pharma Co., Ltd. - CEO, President & Representative Director
* Toru Kimura
Sumitomo Pharma Co., Ltd. - EVP of Global Corporate Strategy, Regenerative & Cellular Medicine Off. and Representative Director
* Yoshiharu Ikeda
Sumitomo Pharma Co., Ltd. - Senior Exe. Officer of Cancer, Modality & Drug Research Div., Head of Japan Busi Unit and Director

=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Shinichiro Muraoka
Morgan Stanley, Research Division - Research Analyst

=====================
Hiroshi Nomura - Sumitomo Pharma Co., Ltd. - CEO, President &

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot